AIM: To evaluate and compare the clinical usefulness of 13C-phenylalanine and 13C-methacetin breath tests in quantitating functional hepatic mass in patients with chronic liver disease and to further compare these results with those of conventional tests, Child-Pugh score and serum bile acid levels. METHODS: One hundred and forty patients (50 HCV-related chronic hepatitis, 90 liver cirrhosis patients) and 40 matched healthy controls were studied. Both breath test and routine liver test, serum levels of cholic and chenodeoxycholic acid conjugates were evaluated. RESULTS: Methacetin breath test, expressed as 60 min cumulative percent of oxidation, discriminated the hepatic functional capacity not only between controls and liver disease patients, but also between different categories of chronic liver disease patients. Methacetin breath test was correlated with liver function tests and serum bile acids. Furthermore, methacetin breath test, as well as serum bile acids, were highly predictive of Child-Pugh scores. The diagnostic power of phenylalanine breath test was always less than that of methacetin breath test. CONCLUSION: Methacetin breath test represents a safe and accurate diagnostic tool in the evaluation of hepatic functional mass in chronic liver disease patients.
AIM: To evaluate and compare the clinical usefulness of 13C-phenylalanine and 13C-methacetin breath tests in quantitating functional hepatic mass in patients with chronic liver disease and to further compare these results with those of conventional tests, Child-Pugh score and serum bile acid levels. METHODS: One hundred and forty patients (50 HCV-related chronic hepatitis, 90 liver cirrhosispatients) and 40 matched healthy controls were studied. Both breath test and routine liver test, serum levels of cholic and chenodeoxycholic acid conjugates were evaluated. RESULTS:Methacetin breath test, expressed as 60 min cumulative percent of oxidation, discriminated the hepatic functional capacity not only between controls and liver diseasepatients, but also between different categories of chronic liver diseasepatients. Methacetin breath test was correlated with liver function tests and serum bile acids. Furthermore, methacetin breath test, as well as serum bile acids, were highly predictive of Child-Pugh scores. The diagnostic power of phenylalanine breath test was always less than that of methacetin breath test. CONCLUSION:Methacetin breath test represents a safe and accurate diagnostic tool in the evaluation of hepatic functional mass in chronic liver diseasepatients.
Authors: A Armuzzi; M Candelli; M A Zocco; A Andreoli; A De Lorenzo; E C Nista; L Miele; F Cremonini; I A Cazzato; A Grieco; G Gasbarrini; A Gasbarrini Journal: Aliment Pharmacol Ther Date: 2002-12 Impact factor: 8.171
Authors: A Armuzzi; S Marcoccia; M A Zocco; A De Lorenzo; A Grieco; P Tondi; P Pola; G Gasbarrini; A Gasbarrini Journal: Scand J Gastroenterol Date: 2000-06 Impact factor: 2.423
Authors: D Festi; A M Morselli Labate; A Roda; F Bazzoli; R Frabboni; P Rucci; F Taroni; R Aldini; E Roda; L Barbara Journal: Hepatology Date: 1983 Sep-Oct Impact factor: 17.425
Authors: Darren S Miller; Anne Michelle Parsons; John Bresland; Paul Herde; Duc Minh Pham; Angel Tan; Hung-yao Hsu; Clive A Prestidge; Tim Kuchel; Rezaul Begg; Syed Mahfuzul Aziz; Ross N Butler Journal: J Zhejiang Univ Sci B Date: 2015-07 Impact factor: 3.066
Authors: Anna Kasicka-Jonderko; Anna Nita; Krzysztof Jonderko; Magdalena Kamińska; Barbara Błońska-Fajfrowska Journal: World J Gastroenterol Date: 2011-12-07 Impact factor: 5.742
Authors: I Gallardo-Wong; S Morán; G Rodríguez-Leal; B Castañeda-Romero; R Mera; J Poo; M Uribe; M Dehesa Journal: World J Gastroenterol Date: 2007-09-14 Impact factor: 5.742